• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Computational analysis of microRNA profiles and their target genes suggests significant involvement in breast cancer antiestrogen resistance.对微小RNA谱及其靶基因的计算分析表明,它们在乳腺癌抗雌激素耐药性中具有重要作用。
Bioinformatics. 2009 Feb 15;25(4):430-4. doi: 10.1093/bioinformatics/btn646. Epub 2008 Dec 17.
2
Differential microRNA profiles between fulvestrant-resistant and tamoxifen-resistant human breast cancer cells.氟维司群耐药和他莫昔芬耐药的人乳腺癌细胞之间的微小RNA差异谱。
Anticancer Drugs. 2018 Jul;29(6):539-548. doi: 10.1097/CAD.0000000000000623.
3
MicroRNA-221/222 confers breast cancer fulvestrant resistance by regulating multiple signaling pathways.MicroRNA-221/222 通过调节多种信号通路赋予乳腺癌氟维司群耐药性。
Oncogene. 2011 Mar 3;30(9):1082-97. doi: 10.1038/onc.2010.487. Epub 2010 Nov 8.
4
An integrative analysis of cellular contexts, miRNAs and mRNAs reveals network clusters associated with antiestrogen-resistant breast cancer cells.对细胞环境、miRNAs 和 mRNAs 的综合分析揭示了与抗雌激素耐药乳腺癌细胞相关的网络簇。
BMC Genomics. 2012 Dec 27;13:732. doi: 10.1186/1471-2164-13-732.
5
Apigenin inhibits antiestrogen-resistant breast cancer cell growth through estrogen receptor-alpha-dependent and estrogen receptor-alpha-independent mechanisms.芹菜素通过雌激素受体α依赖和雌激素受体α非依赖机制抑制抗雌激素耐药乳腺癌细胞的生长。
Mol Cancer Ther. 2008 Jul;7(7):2096-108. doi: 10.1158/1535-7163.MCT-07-2350.
6
Antiestrogen-resistant subclones of MCF-7 human breast cancer cells are derived from a common monoclonal drug-resistant progenitor.MCF-7人乳腺癌细胞的抗雌激素抗性亚克隆源自一个共同的单克隆耐药祖细胞。
Proc Natl Acad Sci U S A. 2009 Aug 25;106(34):14536-41. doi: 10.1073/pnas.0907560106.
7
An empirical Bayes model for gene expression and methylation profiles in antiestrogen resistant breast cancer.抗雌激素耐药乳腺癌中基因表达和甲基化谱的经验贝叶斯模型。
BMC Med Genomics. 2010 Nov 25;3:55. doi: 10.1186/1755-8794-3-55.
8
MicroRNA-519a is a novel oncomir conferring tamoxifen resistance by targeting a network of tumour-suppressor genes in ER+ breast cancer.微小 RNA-519a 通过靶向 ER+ 乳腺癌中的肿瘤抑制基因网络赋予他莫昔芬耐药性,是一种新型致癌 miRNA。
J Pathol. 2014 Aug;233(4):368-79. doi: 10.1002/path.4363. Epub 2014 Jun 2.
9
Characterization of BCAR4, a novel oncogene causing endocrine resistance in human breast cancer cells.鉴定 BCAR4,一种导致人类乳腺癌细胞内分泌抵抗的新型致癌基因。
J Cell Physiol. 2011 Jul;226(7):1741-9. doi: 10.1002/jcp.22503.
10
Association of FGFR1 with ERα Maintains Ligand-Independent ER Transcription and Mediates Resistance to Estrogen Deprivation in ER Breast Cancer.成纤维细胞生长因子受体 1(FGFR1)与雌激素受体α(ERα)的关联维持了配体非依赖性 ER 转录,并介导了 ER 阳性乳腺癌对雌激素剥夺的耐药性。
Clin Cancer Res. 2017 Oct 15;23(20):6138-6150. doi: 10.1158/1078-0432.CCR-17-1232. Epub 2017 Jul 27.

引用本文的文献

1
MicroRNAs as Molecular Biomarkers for the Characterization of Basal-like Breast Tumor Subtype.微小RNA作为基底样乳腺癌亚型特征的分子生物标志物
Biomedicines. 2023 Nov 9;11(11):3007. doi: 10.3390/biomedicines11113007.
2
MiR-590-5p promotes cisplatin resistance via targeting hMSH2 in ovarian cancer.miR-590-5p 通过靶向 hMSH2 促进卵巢癌细胞对顺铂耐药。
Mol Biol Rep. 2023 Aug;50(8):6819-6827. doi: 10.1007/s11033-023-08599-8. Epub 2023 Jul 1.
3
Molecular Mechanisms of Anti-Estrogen Therapy Resistance and Novel Targeted Therapies.抗雌激素治疗耐药性的分子机制及新型靶向治疗
Cancers (Basel). 2022 Oct 24;14(21):5206. doi: 10.3390/cancers14215206.
4
A Survey on Computational Methods for Investigation on ncRNA-Disease Association through the Mode of Action Perspective.ncRNA 疾病关联的计算方法研究综述——从作用模式角度
Int J Mol Sci. 2022 Sep 29;23(19):11498. doi: 10.3390/ijms231911498.
5
Strategies for Improving Photodynamic Therapy Through Pharmacological Modulation of the Immediate Early Stress Response.通过即时早期应激反应的药理学调节来改善光动力疗法的策略。
Methods Mol Biol. 2022;2451:405-480. doi: 10.1007/978-1-0716-2099-1_20.
6
MicroRNA as a Potential Therapeutic Molecule in Cancer.微小 RNA 作为癌症治疗的潜在分子
Cells. 2022 Mar 16;11(6):1008. doi: 10.3390/cells11061008.
7
MicroRNAs and drug resistance in colorectal cancer with special focus on 5-fluorouracil.microRNAs 与结直肠癌的耐药性,特别关注 5-氟尿嘧啶。
Mol Biol Rep. 2022 Jun;49(6):5165-5178. doi: 10.1007/s11033-022-07227-1. Epub 2022 Feb 25.
8
Identification of potential plasma biomarkers in early-stage nasopharyngeal carcinoma-derived exosomes based on RNA sequencing.基于RNA测序鉴定早期鼻咽癌来源外泌体中的潜在血浆生物标志物
Cancer Cell Int. 2021 Mar 31;21(1):185. doi: 10.1186/s12935-021-01881-4.
9
Effects of miR-125b-5p on Preadipocyte Proliferation and Differentiation in Chicken.miR-125b-5p 对鸡前体脂肪细胞增殖和分化的影响。
Mol Biol Rep. 2021 Jan;48(1):491-502. doi: 10.1007/s11033-020-06080-4. Epub 2021 Jan 4.
10
miRNA Expression Profiles in Luminal A Breast Cancer-Implications in Biology, Prognosis, and Prediction of Response to Hormonal Treatment.腔面 A 型乳腺癌中的 miRNA 表达谱——对生物学、预后和激素治疗反应预测的影响。
Int J Mol Sci. 2020 Oct 17;21(20):7691. doi: 10.3390/ijms21207691.

本文引用的文献

1
miR2Disease: a manually curated database for microRNA deregulation in human disease.miR2Disease:一个人工整理的关于人类疾病中 microRNA 失调的数据库。
Nucleic Acids Res. 2009 Jan;37(Database issue):D98-104. doi: 10.1093/nar/gkn714. Epub 2008 Oct 15.
2
Four miRNAs associated with aggressiveness of lymph node-negative, estrogen receptor-positive human breast cancer.四种与淋巴结阴性、雌激素受体阳性的人类乳腺癌侵袭性相关的微小RNA。
Proc Natl Acad Sci U S A. 2008 Sep 2;105(35):13021-6. doi: 10.1073/pnas.0803304105. Epub 2008 Aug 28.
3
Widespread changes in protein synthesis induced by microRNAs.微小RNA诱导的蛋白质合成的广泛变化。
Nature. 2008 Sep 4;455(7209):58-63. doi: 10.1038/nature07228. Epub 2008 Jul 30.
4
The impact of microRNAs on protein output.微小RNA对蛋白质产出的影响。
Nature. 2008 Sep 4;455(7209):64-71. doi: 10.1038/nature07242. Epub 2008 Jul 30.
5
miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells.miR-15b和miR-16通过靶向人胃癌细胞中的BCL2来调节多药耐药性。
Int J Cancer. 2008 Jul 15;123(2):372-379. doi: 10.1002/ijc.23501.
6
Epigenetic gene silencing in the Wnt pathway in breast cancer.乳腺癌中Wnt信号通路的表观遗传基因沉默
Epigenetics. 2008 Mar-Apr;3(2):59-63. doi: 10.4161/epi.3.2.5899. Epub 2008 Mar 12.
7
An integrated approach to the prediction of chemotherapeutic response in patients with breast cancer.一种预测乳腺癌患者化疗反应的综合方法。
PLoS One. 2008 Apr 2;3(4):e1908. doi: 10.1371/journal.pone.0001908.
8
MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN.人类卵巢癌中的微小RNA表达谱分析:miR-214通过靶向PTEN诱导细胞存活和顺铂耐药。
Cancer Res. 2008 Jan 15;68(2):425-33. doi: 10.1158/0008-5472.CAN-07-2488.
9
MicroRNAs modulate the chemosensitivity of tumor cells.微小RNA调节肿瘤细胞的化学敏感性。
Mol Cancer Ther. 2008 Jan;7(1):1-9. doi: 10.1158/1535-7163.MCT-07-0573. Epub 2008 Jan 9.
10
Tumour invasion and metastasis initiated by microRNA-10b in breast cancer.微小RNA-10b引发的乳腺癌肿瘤侵袭与转移
Nature. 2007 Oct 11;449(7163):682-8. doi: 10.1038/nature06174. Epub 2007 Sep 26.

对微小RNA谱及其靶基因的计算分析表明,它们在乳腺癌抗雌激素耐药性中具有重要作用。

Computational analysis of microRNA profiles and their target genes suggests significant involvement in breast cancer antiestrogen resistance.

作者信息

Xin Fuxiao, Li Meng, Balch Curt, Thomson Michael, Fan Meiyun, Liu Yunlong, Hammond Scott M, Kim Sun, Nephew Kenneth P

机构信息

School of Informatics, Indiana University, Bloomington, IN 47405, USA.

出版信息

Bioinformatics. 2009 Feb 15;25(4):430-4. doi: 10.1093/bioinformatics/btn646. Epub 2008 Dec 17.

DOI:10.1093/bioinformatics/btn646
PMID:19091772
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2642642/
Abstract

MOTIVATION

Recent evidence shows significant involvement of microRNAs (miRNAs) in the initiation and progression of numerous cancers; however, the role of these in tumor drug resistance remains unknown.

RESULTS

By comparing global miRNA and mRNA expression patterns, we examined the role of miRNAs in resistance to the 'pure antiestrogen' fulvestrant, using fulvestrant-resistant MCF7-FR cells and their drug-sensitive parental estrogen receptor (ER)-positive MCF7 cells. We identified 14 miRNAs downregulated in MCF7-FR cells and then used both TargetScan and PITA to predict potential target genes. We found a negative correlation between expression of these miRNAs and their predicted target mRNA transcripts. In genes regulated by multiple miRNAs or having multiple miRNA-targeting sites, an even stronger negative correlation was found. Pathway analyses predicted these miRNAs to regulate specific cancer-associated signal cascades. These results suggest a significant role for miRNA-regulated gene expression in the onset of breast cancer antiestrogen resistance, and an improved understanding of this phenomenon could lead to better therapies for this often fatal condition.

摘要

动机

近期证据表明,微小RNA(miRNA)在多种癌症的发生和发展中发挥着重要作用;然而,它们在肿瘤耐药性中的作用仍不清楚。

结果

通过比较整体miRNA和mRNA表达模式,我们利用氟维司群耐药的MCF7-FR细胞及其药物敏感的亲代雌激素受体(ER)阳性MCF7细胞,研究了miRNA在对“纯抗雌激素药物”氟维司群耐药中的作用。我们鉴定出14种在MCF7-FR细胞中表达下调的miRNA,然后使用TargetScan和PITA预测潜在的靶基因。我们发现这些miRNA的表达与其预测的靶mRNA转录本之间呈负相关。在受多个miRNA调控或具有多个miRNA靶向位点的基因中,发现了更强的负相关。通路分析预测这些miRNA可调节特定的癌症相关信号级联反应。这些结果表明,miRNA调控的基因表达在乳腺癌抗雌激素耐药的发生中起重要作用,更好地理解这一现象可能会为这种常致命的疾病带来更好的治疗方法。